HRCU sponsors Banzai for elementary schools
Staff Report
ROCHESTER HRCU is bringing financial literacy education to more than 1,500 elementary students in the Rochester and Strafford school districts. Students at 8 Rochester elementary schools and 1 Strafford elementary school will now have free access to Banzai, an award-winning online program and content library that allows students to practice real-world finance using any internet-enabled device.
Through the Banzai online courses, students try out managing a budget, saving for a goal, and dealing with unexpected financial pitfalls. Teachers can easily monitor and grade student progress in the classroom or remotely.
“Sponsoring Banzai for the elementary school provides teachers and parents with a tool that can help teach their students and children important financial lessons,” said Brian Hughes, President & CEO of HRCU. “We truly care about the financial wellness of those in our community and hope they will find thes
Gonic-school
New-hampshire
United-states
William-allen-school
Barrington-middle-school
East-rochester-school
Oyster-river-high-school
Somersworth-high-school
Nancy-loud-school
Leah-taylor
Brian-hughes
Rochester-school
Share this article
Share this article
SOUTH SAN FRANCISCO, Calif., April 20, 2021 /PRNewswire/ Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Celia Lin, MD, as Chief Medical Officer. Dr. Lin brings extensive clinical and industry experience in orphan diseases and multiple therapeutic areas, including nephrology and inflammation. In addition, the Company announced the appointments of Tad Thomas, PhD, as Senior Vice President (SVP) and Head of Product Development and Manufacturing and Joseph Young, MBA, as SVP of Finance.
Vera Therapeutics Appoints Industry Veteran Dr. Celia Lin as Chief Medical Officer
Berkeley
California
United-states
Boston
Massachusetts
Los-angeles
San-francisco
Daiichi-sankyo
University-of-california
Amgen
Genentech
Plexxikon-inc